Filing Flows › Core Laboratories (CLB) › Q1 2026
Core Laboratories (CLB) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 1, 2026
Core Laboratories (CLB) reported revenue of $122M for the first quarter 2026 (Q1 2026), -1% from a year earlier and -12% from the quarter before. Operating margin was 1.5%, net loss $753K (0.6% of revenue).
Core Laboratories, Q1 2026: revenue $122M (-1% year over year), operating margin 1.5%, net loss $753K, operating cash flow $4.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $122M | -12% | -1% |
| Operating profit | $1.9M | -88% | -57% |
| Net earnings | −$753K | -115% | -1191% |
| Operating cash flow | $4.0M | -50% | -40% |
| Free cash flow | $517K | — | — |
What changed
Revenue was $121.8M in Q1 2026, down 1% year over year and down 12% from the previous quarter. Service was the largest line at 77% of revenue. Product lost $949K year over year (down 3%), 53% of the total change.
Operating profit was $1.9M, a 1.5% margin (down 2.0 points year over year). Total costs grew 1% against a revenue fall of 1%. The quarter ended with a net loss of $753K, after a profit of $5.1M the previous quarter. Net interest and other expense of $2.9M was the main reason.
Operating cash flow was $4.0M (down 40% year over year). Non-cash charges added back $3.8M of depreciation and amortization and $5.0M of share-based compensation. Working capital and other items used $4.1M. After capital expenditures - operations ($3.4M), free cash flow as the company reports it was $517K.
Questions
What was Core Laboratories' revenue in the first quarter 2026?
Core Laboratories (CLB) reported revenue of $122M for the first quarter 2026 (Q1 2026), -1% from a year earlier and -12% from the quarter before.
Was Core Laboratories profitable in the first quarter 2026?
Operating profit was $1.9M (1.5% of revenue) and net loss $753K.
Source: Core Laboratories 10-Q on SEC EDGAR.